1226985-36-9

Basic information

• Product Name: 3H-Indazol-3-one, 6-bromo-1,2-dihydro-1-methyl-
• CAS NO: 1226985-36-9
• Mol File: 1226985-36-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3H-Indazol-3-one, 6-bromo-1,2-dihydro-1-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 3H-Indazol-3-one, 6-bromo-1,2-dihydro-1-methyl-(1226985-36-9)
• EPA Substance Registry System: 3H-Indazol-3-one, 6-bromo-1,2-dihydro-1-methyl-(1226985-36-9)

Safety Data

• Hazardous Substances Data: 1226985-36-9(Hazardous Substances Data)

Upstream product

• 22038-72-8 methyldiazene 
• 179232-29-2 methyl 4-bromo-2-fluorobenzoate 
• 17405-06-0 N-(3-bromophenyl)-N-methylnitrous amide 
• 66584-32-5 3-bromo-N-methylaniline 
• 112704-79-7 2-fluoro-4-bromobenzoic acid 
• 60-34-4 methylhydrazine 

Relevant articles and documents

INDAZOLE COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION

Indazole compounds which are useful as allosteric potentiators/positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds, for example, in treating neurological and psychiatric disorders or other disease states associated with glutamate dysfunction.

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- or combinations thereof.